TEHRAN –An Iranian knowledge-based company has announced readiness to meet the needs of regional countries as well as North Africa for the human papillomavirus (HPV) vaccine. Producing the HPV vaccine needs one of the most complicated technologies in the world, and Iran has been able to produce the vaccine domestically. Passing quality control tests and pre-clinical trials, the clinical trial of the HPV vaccine started in 2019 on healthy volunteers. Cancer therapyOn March 17, A cancer treatment center, which is said to be the most advanced of its kind in the region, was officially inaugurated by President Ebrahim Raisi. The program includes two important documents, namely, “development of national cancer care network” and “development of cancer human resources”, which resulted in the establishment of the early diagnostic centers.

Source: The North Africa Journal January 13, 2024 14:40 UTC